Studies have increasingly pointed out the role of TP53TG1 in the progression of various cancers, where its expression is altered in several tumors, including hepatocellular carcinoma, breast cancer, gastric cancer, non-small cell lung cancer, colorectal cancer, and glioma. This evidence concerns the gene TP53TG1 and central nervous system cancer.